200 related articles for article (PubMed ID: 28940724)
1. Acral melanoma foot lesions. Part 1: epidemiology, aetiology, and molecular pathology.
Desai A; Ugorji R; Khachemoune A
Clin Exp Dermatol; 2017 Dec; 42(8):845-848. PubMed ID: 28940724
[TBL] [Abstract][Full Text] [Related]
2. Acral melanoma foot lesions. Part 2: clinical presentation, diagnosis, and management.
Desai A; Ugorji R; Khachemoune A
Clin Exp Dermatol; 2018 Mar; 43(2):117-123. PubMed ID: 29235153
[TBL] [Abstract][Full Text] [Related]
3. Melanoma in non-caucasian populations.
Stubblefield J; Kelly B
Surg Clin North Am; 2014 Oct; 94(5):1115-26, ix. PubMed ID: 25245971
[TBL] [Abstract][Full Text] [Related]
4. Acral Lentiginous Melanoma.
Goydos JS; Shoen SL
Cancer Treat Res; 2016; 167():321-9. PubMed ID: 26601870
[TBL] [Abstract][Full Text] [Related]
5. Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review.
Durbec F; Martin L; Derancourt C; Grange F
Br J Dermatol; 2012 Apr; 166(4):727-39. PubMed ID: 22175696
[TBL] [Abstract][Full Text] [Related]
6. More than just acral melanoma: the controversies of defining the disease.
Bernardes SS; Ferreira I; Elder DE; Nobre AB; Martínez-Said H; Adams DJ; Robles-Espinoza CD; Possik PA
J Pathol Clin Res; 2021 Nov; 7(6):531-541. PubMed ID: 34213090
[TBL] [Abstract][Full Text] [Related]
7. Acral melanoma: correlating the clinical presentation to the mutational status.
Ravaioli GM; Dika E; Lambertini M; Chessa MA; Fanti PA; Patrizi A
G Ital Dermatol Venereol; 2019 Oct; 154(5):567-572. PubMed ID: 29512974
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of β-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2.
Xu S; Yang Z; Zhang J; Jiang Y; Chen Y; Li H; Liu X; Xu D; Chen Y; Yang Y; Zhang Y; Li D; Xia J
DNA Cell Biol; 2015 Jan; 34(1):69-77. PubMed ID: 25343173
[TBL] [Abstract][Full Text] [Related]
9. The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI).
Elefanti L; Zamuner C; Del Fiore P; Stagni C; Pellegrini S; Dall'Olmo L; Fabozzi A; Senetta R; Ribero S; Salmaso R; Mocellin S; Bassetto F; Cavallin F; Tosi AL; Galuppini F; Dei Tos AP; Menin C; Cappellesso R
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917086
[TBL] [Abstract][Full Text] [Related]
10. Genetic characteristics and response to systemic therapies of acral lentiginous melanoma at a tertiary care center-a retrospective review.
Jamerson T; Rebecca VW; Aguh C
J Natl Med Assoc; 2022 Feb; 114(1):7-11. PubMed ID: 34509302
[TBL] [Abstract][Full Text] [Related]
11. Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.
Gui J; Guo Z; Wu D
J Transl Med; 2022 Aug; 20(1):367. PubMed ID: 35974375
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acral and mucosal melanoma: Current and emerging targeted therapies.
Zhang J; Tian H; Mao L; Si L
Crit Rev Oncol Hematol; 2024 Jan; 193():104221. PubMed ID: 38036156
[TBL] [Abstract][Full Text] [Related]
13.
Ponti G; Manfredini M; Greco S; Pellacani G; Depenni R; Tomasi A; Maccaferri M; Cascinu S
Anticancer Res; 2017 Dec; 37(12):7043-7048. PubMed ID: 29187493
[TBL] [Abstract][Full Text] [Related]
14. Multiple primary acral melanomas in two young caucasian patients.
Lacruz G; Cárdenas I; Carrera C; Díaz A; Puig-Butillè JA; Badenas C; Malvehy J; Puig S
Dermatology; 2014; 228(4):307-10. PubMed ID: 24942556
[TBL] [Abstract][Full Text] [Related]
15. Mucosal Melanoma: Epidemiology, Biology and Treatment.
Spencer KR; Mehnert JM
Cancer Treat Res; 2016; 167():295-320. PubMed ID: 26601869
[TBL] [Abstract][Full Text] [Related]
16. A clinicopathologic analysis of 177 acral melanomas in Koreans: relevance of spreading pattern and physical stress.
Jung HJ; Kweon SS; Lee JB; Lee SC; Yun SJ
JAMA Dermatol; 2013 Nov; 149(11):1281-8. PubMed ID: 24067997
[TBL] [Abstract][Full Text] [Related]
17. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Management of Acral Lentiginous Melanoma.
Nakamura Y; Fujisawa Y
Curr Treat Options Oncol; 2018 Jun; 19(8):42. PubMed ID: 29951919
[TBL] [Abstract][Full Text] [Related]
19. KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma.
Zebary A; Omholt K; Vassilaki I; Höiom V; Lindén D; Viberg L; Kanter-Lewensohn L; Johansson CH; Hansson J
J Dermatol Sci; 2013 Dec; 72(3):284-9. PubMed ID: 23993026
[TBL] [Abstract][Full Text] [Related]
20. Advanced Acral Melanoma Therapies: Current Status and Future Directions.
Zhang Y; Lan S; Wu D
Curr Treat Options Oncol; 2022 Oct; 23(10):1405-1427. PubMed ID: 36125617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
